The healthcare giant just took a major step that could reshape its MedTech business and boost its dividend track record.
This investment follows the company’s successful 2025 closing of its $150M Series G round, led by Revival Healthcare Capital. Distalmotion focuses on the growing need for a purpose-built robotic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results